These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22273841)

  • 81. Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.
    Simeoni E; Dudler J; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):222-8. PubMed ID: 17182252
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.
    Li J; Meinhardt A; Roehrich ME; Golshayan D; Dudler J; Pagnotta M; Trucco M; Vassalli G
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3415-23. PubMed ID: 17933973
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.
    Wolf D; Schreiber TH; Tryphonopoulos P; Li S; Tzakis AG; Ruiz P; Podack ER
    Transplantation; 2012 Sep; 94(6):569-74. PubMed ID: 22902792
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A significant role for anti-human leukocyte antigen antibodies and antibody-mediated rejection in the biopsy-for-cause population.
    Banasik M; Kościelska-Kasprzak K; Myszka M; Bartoszek D; Zabińska M; Boratyńska M; Kamińska D; Mazanowska O; Zmonarski S; Krajewska M; Hałoń A; Dawiskiba T; Nowakowska B; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2613-7. PubMed ID: 25380878
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.
    Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ
    Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Favorable Outcome of an Exclusively Posttransplant Prophylactic Strategy After Heart Transplantation in Recipients With High Immunological Risk.
    Coutance G; d'Orio V; Belin L; Bréchot N; Saheb S; Lebreton G; Bouglé A; Rouvier P; Gautreau C; Ouldammar S; Chamillard X; Huot M; Amour J; Combes A; Leprince P; Varnous S
    Transplantation; 2019 Jul; 103(7):1439-1449. PubMed ID: 30376551
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.
    Michielsen LA; Wisse BW; Kamburova EG; Verhaar MC; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; van Zuilen AD
    Nephrol Dial Transplant; 2019 Jun; 34(6):1056-1063. PubMed ID: 30365008
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
    Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
    Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
    Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity.
    McKee CM; Defina R; He H; Haley KJ; Stone JR; Perkins DL
    J Immunol; 2002 Jan; 168(1):483-9. PubMed ID: 11751996
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Determination of Cytokine Gene Polymorphisms in a Heart Transplant Patient Resistant to Desensitization Therapy: Case Report.
    Baştürk B; Kavuzlu M; Khalilova A; Kantaroğlu B; Sezgin A
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):113-116. PubMed ID: 35384819
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance.
    Smyth LA; Meader L; Xiao F; Woodward M; Brady HJ; Lechler R; Lombardi G
    Clin Exp Immunol; 2017 May; 188(2):219-225. PubMed ID: 28120329
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Impact of donor-specific anti-HLA antibody on cardiac hemodynamics and graft function 3 years after pediatric heart transplantation: First results from the CTOTC-09 multi-institutional study.
    Webber SA; Chin H; Wilkinson JD; Armstrong BD; Canter CE; Dipchand AI; Dodd DA; Feingold B; Lamour JM; Mahle WT; Singh TP; Zuckerman WA; Rossano JW; Morrison Y; Diop H; Demetris AJ; Bentlejewski C; Mohanakumar T; Odim J; Zeevi A;
    Am J Transplant; 2023 Dec; 23(12):1893-1907. PubMed ID: 37579817
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Animal Models for Heart Transplantation Focusing on the Pathological Conditions.
    Tseng HT; Lin YW; Huang CY; Shih CM; Tsai YT; Liu CW; Tsai CS; Lin FY
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239085
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights.
    Kervella D; Le Bas-Bernardet S; Bruneau S; Blancho G
    Front Immunol; 2022; 13():932242. PubMed ID: 35990687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.